A Study in Participants with Non-cirrhotic NASH with Fibrosis

Trial Identifier: D6581C00001
Sponsor: AstraZeneca
NCTID:: NCT05638737
Start Date: October 2022
Primary Completion Date: April 2024
Study Completion Date: April 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AR CABA, AR, C1119ACN
AR CABA, AR, C1426
AR CABA, AR, C1056ABJ
AR Ciudad de Buenos Aires, AR, 1280
AR Mar del Plata, AR, 7600
AR Ramos Mejía, AR, B1704ETD
DK Aarhus N, DK, 8200
DK Esbjerg, DK, 6700
DK København NV, DK, 2400
DK Koge, DK, 4600
ES La Coruña, ES, 15006
ES Lérida, ES, 25198
ES Madrid, ES, 28046
ES Málaga, ES, 29010
ES Pozuelo de Alarcon, ES, 28223
ES Santander, ES, 39008
ES Valencia, ES, 46014
IT CATANIA, IT, 95100
IT Foggia, IT, 71100
IT MILAN, IT, 20122
IT Milano, IT, 20132
IT Roma, IT, 00128
IT Roma, IT, 00168
IT Rozzano, IT, 20089
IT SAN GIOVANNI ROTONDO, IT, 71013
IT Torino, IT, 10126
MX Ciudad de Mexico, MX, 06700
MX Guadalajara, MX, 44340
MX Guadalajara, MX, 44210
MX Guadalajara, MX, 44670
MX México, MX, 03300
MX Mexico City, MX, 03330
MX Monterrey, MX, 64000
NO Grålum, NO, 1714
NO Lørenskog, NO, N-1478
NO Oslo, NO, 0456
NO TROMSØ, NO, N-9038
PT Lisboa, PT, 1250-189
SE Linköping, SE, 581 85
SE Uppsala, SE, 751 85
US, AZ Chandler, AZ, US, 85224
US, AZ Tucson, AZ, US, 85712
US, CA Chula Vista, CA, US, 91911
US, CA Montclair, CA, US, 91763
US, CA Orange, CA, US, 92868
US, CA Redondo Beach, CA, US, 90277
US, CA Stanford, CA, US, 94305
US, FL Jacksonville, FL, US, 32256
US, FL Lakeland, FL, US, 33813
US, FL Miami, FL, US, 33135
US, NV Las Vegas, NV, US, 89109
US, NY Yonkers, NY, US, 10701
US, TX San Antonio, TX, US, 78229